Medicine Description temodal 250mg
Temodal 250 mg 5 capsules is a medication that contains the active ingredient temozolomide, an oral alkylating agent used primarily in the treatment of specific types of cancer. Its mechanism of action involves the methylation of DNA at the O6 position of guanine, which leads to DNA strand breaks and ultimately triggers apoptosis in rapidly dividing tumor cells. This process hinders the cancer cells' ability to replicate and proliferate, thereby contributing to tumor size reduction and delaying disease progression. The drug is particularly effective in treating gliomas and other certain brain tumors, often utilized in conjunction with radiotherapy to enhance therapeutic outcomes.
Indications and Uses of Temodal 250 mg 5 capsules
- Treatment of glioblastoma multiforme, particularly after surgical resection and radiation therapy.
- Management of anaplastic astrocytoma after disease progression following standard therapy.
- Used as a part of combination therapy in advanced-stage brain tumors.
Side Effects of Temodal 250 mg 5 capsules
- Nausea and vomiting
- Fatigue
- Loss of appetite
- Constipation
- Headache
- Myelosuppression, leading to decreased blood cell counts
- Increased risk of infections due to neutropenia
Storage and Handling
Store Temodal 250 mg 5 capsules at room temperature, away from light and moisture. Keep out of reach of children. Do not store in the bathroom. Ensure the medication is kept in its original packaging until use to maintain stability.
Patient Advice and Precautions
Patients should be advised to maintain regular follow-up appointments for blood tests to monitor blood cell counts during treatment. It is crucial to report any unusual symptoms, such as signs of infection (fever, chills) or unusual bruising/bleeding, to a healthcare provider immediately. A balanced diet and adequate hydration are encouraged to support overall health during therapy. Patients should also be informed about the risk of potential interactions with other medications and the importance of discussing any new treatments with their healthcare provider.